Email this article Safety assessment and determination of a maximally tolerated dose of an RAS-GTPase inhibitor (iRAS) in the treatment of gastrointestinal tumors: preliminary results of the phase I trial - PDF (Russian)
Copyright (c) 2023 Bozhenko V.K., Goncharov S.V., Kudinova E.A., Kulinich T.M., Kukoleva E.A., Filippov M.S., Bykova A.F., Knyazeva O.B., Puchkov I.A., Solodkiy V.A.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.